Baolingbao BiologyLtd Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Baolingbao BiologyLtd.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Food earnings growth | 22.3% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
Recent updates
Baolingbao BiologyLtd (SZSE:002286) Strong Profits May Be Masking Some Underlying Issues
Nov 05Baolingbao Biology Co.,Ltd.'s (SZSE:002286) Shares Climb 36% But Its Business Is Yet to Catch Up
Oct 08We Like These Underlying Return On Capital Trends At Baolingbao BiologyLtd (SZSE:002286)
Sep 30Baolingbao Biology Co.,Ltd.'s (SZSE:002286) Business Is Yet to Catch Up With Its Share Price
Jul 03Returns On Capital At Baolingbao BiologyLtd (SZSE:002286) Have Stalled
Jun 07Earnings Troubles May Signal Larger Issues for Baolingbao BiologyLtd (SZSE:002286) Shareholders
May 06In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Baolingbao BiologyLtd has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2024 | 2,392 | 109 | 41 | 175 | N/A |
6/30/2024 | 2,428 | 91 | 114 | 239 | N/A |
3/31/2024 | 2,465 | 60 | 122 | 267 | N/A |
12/31/2023 | 2,524 | 54 | 130 | 282 | N/A |
9/30/2023 | 2,597 | 69 | 22 | 118 | N/A |
6/30/2023 | 2,612 | 75 | 50 | 159 | N/A |
3/31/2023 | 2,665 | 107 | 4 | 168 | N/A |
1/1/2023 | 2,713 | 133 | -224 | 31 | N/A |
9/30/2022 | 2,769 | 152 | -251 | 35 | N/A |
6/30/2022 | 2,886 | 228 | -343 | -85 | N/A |
3/31/2022 | 2,868 | 235 | -149 | 24 | N/A |
1/1/2022 | 2,765 | 202 | 113 | 206 | N/A |
9/30/2021 | 2,589 | 157 | 5 | 191 | N/A |
6/30/2021 | 2,300 | 71 | 65 | 251 | N/A |
3/31/2021 | 2,209 | 45 | 109 | 282 | N/A |
12/31/2020 | 2,055 | 50 | 267 | 398 | N/A |
9/30/2020 | 2,037 | 49 | 507 | 554 | N/A |
6/30/2020 | 1,955 | 54 | 451 | 486 | N/A |
3/31/2020 | 1,810 | 39 | 317 | 370 | N/A |
12/31/2019 | 1,805 | 35 | 58 | 154 | N/A |
9/30/2019 | 1,785 | 39 | -63 | 100 | N/A |
6/30/2019 | 1,778 | 30 | -136 | 27 | N/A |
3/31/2019 | 1,740 | 39 | -118 | 46 | N/A |
12/31/2018 | 1,730 | 43 | -41 | 133 | N/A |
9/30/2018 | 1,649 | 51 | -18 | 72 | N/A |
6/30/2018 | 1,615 | 50 | N/A | 127 | N/A |
3/31/2018 | 1,605 | 50 | N/A | 4 | N/A |
12/31/2017 | 1,593 | 50 | N/A | -37 | N/A |
9/30/2017 | 1,583 | 52 | N/A | 80 | N/A |
6/30/2017 | 1,553 | 55 | N/A | 101 | N/A |
3/31/2017 | 1,477 | 50 | N/A | 124 | N/A |
12/31/2016 | 1,377 | 49 | N/A | 109 | N/A |
9/30/2016 | 1,271 | 45 | N/A | 108 | N/A |
6/30/2016 | 1,200 | 42 | N/A | 146 | N/A |
3/31/2016 | 1,175 | 39 | N/A | 126 | N/A |
12/31/2015 | 1,196 | 41 | N/A | 77 | N/A |
9/30/2015 | 1,155 | 28 | N/A | 100 | N/A |
6/30/2015 | 1,078 | 26 | N/A | 25 | N/A |
3/31/2015 | 992 | 24 | N/A | -4 | N/A |
12/31/2014 | 911 | 23 | N/A | 102 | N/A |
9/30/2014 | 941 | 34 | N/A | 26 | N/A |
6/30/2014 | 963 | 41 | N/A | 45 | N/A |
3/31/2014 | 901 | 41 | N/A | 110 | N/A |
12/31/2013 | 901 | 41 | N/A | 86 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 002286's forecast earnings growth is above the savings rate (2.8%).
Earnings vs Market: Insufficient data to determine if 002286's earnings are forecast to grow faster than the CN market
High Growth Earnings: Insufficient data to determine if 002286's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 002286's revenue is forecast to grow faster than the CN market.
High Growth Revenue: Insufficient data to determine if 002286's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 002286's Return on Equity is forecast to be high in 3 years time